Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alzeca Biosciences

Request full access

Healthcare diagnostic company

Houston, United StatesFounded 2012Health Tech & Medtech

About Alzeca Biosciences

Alzeca Biosciences is a medical diagnostics company specializing in the development of advanced imaging agents for the early detection of neurodegenerative diseases, with a primary focus on Alzheimer's disease. The company is developing a proprietary, targeted MRI contrast agent that aims to identify the beta-amyloid plaques associated with early-stage Alzheimer's. This technology is designed to work with conventional MRI systems, potentially offering a more accessible and cost-effective diagnostic tool compared to other advanced imaging methods.

The company's business model centers on the research and development of these novel imaging agents, with the goal of bringing them to market to improve early diagnosis and patient outcomes. By enabling earlier detection, Alzeca's technology could help facilitate timely therapeutic intervention and disease management. The company serves the healthcare and medical diagnostics market, with a focus on neurological disorders.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
54.1/100
Industry
Health
Sub-industry
Health Platform
Sector
Alzheimers Disease, Spinout, DT and LS, science-based
Technology
Artificial Intelligence, Big Data, Deep Tech, Computer Vision
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Oct 2019 $0 — Undisclosed —
SERIES A✓Equity / VC Aug 2017 $11M $44M Dolby Family Ventures —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Alzeca Biosciences website traffic

Latest recorded traffic for Alzeca Biosciences is 180 monthly website visits, up 200% over the last three months. Alzeca Biosciences's team declined 16.7% over the past year.

Latest monthly visits180 3-month web change+200% 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Alzeca Biosciences in the Houston ecosystem

Live from Dealroom

The Alzeca Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Dolby Family Ventures

Other known investors3 additional known investors

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alzeca Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alzeca Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.